Foster & Motley »

Halozyme Therapeutics shares owned by Foster & Motley

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Foster & Motley from 13F filings

Historical chart of Foster & Motley investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Foster & Motley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Foster & Motley

Quarter filed Position value Share count Share price at filing
2024-09-30 $609k 11k 57.18

More positions owned by Foster & Motley

Schwab Fundamental Intl Lg Co ETF Etf (FNDF)
Schwab International Equity ETF Etf (SCHF)
Hartford Multifactor Developed Markets ETF Etf (RODM)
Apple (AAPL)
Janus Henderson Mortgage-Backed ETF Etf (JMBS)
Schwab Fundamental Emerg Mkts Lg Co ETF Etf (FNDE)
Avantis Emerging Markets Equity ETF Etf (AVEM)
Schwab Intermediate-Term U.S. Trsy ETF Etf (SCHR)
Cambria Emerging Shareholder Yield ETF Etf (EYLD)
Vanguard Reit Index ETF Etf (VNQ)
Microsoft Corporation (MSFT)
Managed Portfolio Ser tortoise nram pi (TPYP)
Schwab U.S. REIT ETF Etf (SCHH)
Schwab US TIPS ETF Etf (SCHP)
Oracle Corporation (ORCL)

View all positions for Foster & Motley

Top funds holding Halozyme Therapeutics

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Macquarie Group
Geode Capital Management
Jpmorgan Chase & Co
Congress Asset Management
Bank of America Corporation
Arrowpoint Asset Management
Handelsbanken Fonder AB
Invesco

View all funds holding Halozyme Therapeutics